Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developing inhaled protein therapeutics for lung diseases
Abigail Ann Matthews, Pui Lai Rachel Ee, Ruowen Ge
Molecular Biomedicine (2020) Vol. 1, Iss. 1
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
Ellenmae W. X. Leong, Ruowen Ge
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2179-2179
Open Access | Times Cited: 69
Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol
Michael Neary, Lianne M. Mulder, Piotr S. Kowalski, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 812-833
Open Access | Times Cited: 16
Oral inhalation for delivery of proteins and peptides to the lungs
Eleonore Fröhlich, Sharareh Salar-Behzadi
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 163, pp. 198-211
Open Access | Times Cited: 72
Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections
Hilal Ahmad Parray, Shivangi Shukla, Reshma Perween, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 16-17, pp. 6315-6332
Open Access | Times Cited: 71
Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers
Rudra Pangeni, Tuo Meng, Sagun Poudel, et al.
International Journal of Pharmaceutics (2023) Vol. 634, pp. 122661-122661
Open Access | Times Cited: 32
Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine
Elena Cojocaru, Ovidiu Rusalim Petriș, Cristian Cojocaru
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1059-1059
Open Access | Times Cited: 8
Engineering the right formulation for enhanced drug delivery
Wei-Ren Ke, Rachel Yoon Kyung Chang, Hak‐Kim Chan
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114561-114561
Closed Access | Times Cited: 34
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals
Fakhrossadat Emami, Mahsa Keihan Shokooh, Seyed Jamaleddin Mostafavi Yazdi
Journal of Pharmaceutical Investigation (2022) Vol. 53, Iss. 1, pp. 35-57
Open Access | Times Cited: 32
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
Xiyue He, Xiaohong Chen, Hairui Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 655-674
Open Access | Times Cited: 21
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
Emiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 711
Closed Access | Times Cited: 19
A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases
Fabian Bohländer
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Opportunities for nanomaterials in enzyme therapy
Beatriz Torres-Herrero, Ilaria Armenia, Cecilia Ortiz, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 619-647
Open Access | Times Cited: 7
In Vitro Evaluation of Colistin Conjugated with Chitosan-Capped Gold Nanoparticles as a Possible Formulation Applied in a Metered-Dose Inhaler
Narumon Changsan, Apichart Atipairin, Poowadon Muenraya, et al.
Antibiotics (2024) Vol. 13, Iss. 7, pp. 630-630
Open Access | Times Cited: 6
Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations
Karolina Knap, Konrad Kwiecień, Katarzyna Reczyńska, et al.
Regenerative Biomaterials (2022) Vol. 10
Open Access | Times Cited: 23
Biotin receptor-mediated intracellular delivery of synthetic polypeptide-protein complexes
H. Li, Gordon Bruce, Nick Childerhouse, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 333-341
Open Access | Times Cited: 13
Spray-Dried Nanolipid Powders for Pulmonary Drug Delivery: A Comprehensive Mini Review
Mahmoud H. Abu Elella, Arwa Omar Al Khatib, Hisham Al-Obaidi
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 680-680
Open Access | Times Cited: 5
Structural modifications for the conversion of proteins and peptides into stable dried powder formulations: A review
Wiktoria Brytan, Luís Padrela
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 104992-104992
Open Access | Times Cited: 11
Navigating the Development of Dry Powder for Inhalation: A CDMO Perspective
Beatriz Noriega-Fernandes, Mariam Ibrahim, R.B. Cruz, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 434-434
Open Access
Inhaled antibodies: Quality and performance considerations
Anthony J. Hickey, Ian E. Stewart
Human Vaccines & Immunotherapeutics (2021) Vol. 18, Iss. 2
Open Access | Times Cited: 24
Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics
Rachel Yoon Kyung Chang, Hak‐Kim Chan
Pharmaceutical Research (2022) Vol. 39, Iss. 12, pp. 3047-3061
Open Access | Times Cited: 18
Stimuli-Responsive Hydrogels for Protein Delivery
Rafaela Malta, Ana Camila Marques, Paulo Costa, et al.
Gels (2023) Vol. 9, Iss. 10, pp. 802-802
Open Access | Times Cited: 10
Pulmonary delivery of immune checkpoint inhibitors using a responsive polyethylene glycol nanogel for treating lung metastasis
Yuanyuan Zhao, Xingdi Cheng, Jingjiao Li, et al.
Nano Today (2023) Vol. 52, pp. 101988-101988
Closed Access | Times Cited: 9
Excipients for Novel Inhaled Dosage Forms: An Overview
Carol Yousry, Mimansa Goyal, Vivek Gupta
AAPS PharmSciTech (2024) Vol. 25, Iss. 2
Closed Access | Times Cited: 3
Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosis
Matteo Puccetti, Marilena Pariano, Claudia Stincardini, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 1023-1036
Closed Access | Times Cited: 14
Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial
Bruno Maranda, Sébastien M. Labbé, Magali Lurquin, et al.
The Lancet Infectious Diseases (2023)
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top